1
|
Bayram S, Oduncu M, Beşkoç C, Atan Y. Orthopedic Surgeons at Greater Risk of Malpractice Claims for Treatment of Primary Malignant Bone and Soft Tissue Tumors Compared With Metastatic Bone Disease. J Surg Oncol 2024. [PMID: 39665693 DOI: 10.1002/jso.28009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2024] [Accepted: 10/29/2024] [Indexed: 12/13/2024]
Abstract
BACKGROUND The aim of this study was to examine cases of malpractice litigation in primary sarcoma and metastatic bone disease in orthopedic oncology, to identify the areas in which orthopedic surgeons may be guilty of negligence, and to make them aware of this. METHODS A comprehensive examination was conducted on all closed medical malpractice cases involving bone and soft tissue malignant tumors from 2014 to 2024. Patient demographics, histopathological diagnosis, and malpractice claims made in a variety of specialties were recorded. The inclusion and exclusion criteria of the study resulted in the inclusion of 70 cases of primary bone and soft tissue sarcoma and 36 cases of metastatic bone disease. RESULTS A total of 47 primary tumors were bone sarcoma and 23 were soft tissue sarcoma. A total of 11 patients with primary sarcoma were accepted for malpractice claims, representing 16% of all cases within this category. Nevertheless, no evidence of malpractice was identified among the patients with metastatic bone disease (p = 0.012). Orthopedists (44 of 85 defendants), pathologists (14 of 85 defendants), and radiologists (7 of 85 defendants) were the most common defendants in primary sarcoma malpractice cases. Surgeons other than orthopedists (21 of 49 defendants), medical oncologists (4 of 49 defendants), and radiation oncologists (4 of 49 defendants) were the most common defendants in metastatic bone disease malpractice cases. CONCLUSION Analysis of our cases suggests that malpractice claims are more likely filed against orthopedic surgeons for the treatment of primary malignant bone and soft tissue tumors than for metastatic bone disease.
Collapse
Affiliation(s)
- Serkan Bayram
- Department of Orthopedics and Traumatology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
- Council of Forensic Medicine, Istanbul, Turkey
| | | | | | - Yusuf Atan
- Council of Forensic Medicine, Istanbul, Turkey
| |
Collapse
|
2
|
Dronkers WJ, Buis DR, Amelink QJMA, Bouma GJ, Peul WC, Vandertop WP, Broekman MLD, Hendriks AC, Dirven CMF, Spoor JKH. Medical Malpractice in Neurosurgery: An Analysis of Claims in the Netherlands. Neurosurgery 2024:00006123-990000000-01298. [PMID: 39058041 DOI: 10.1227/neu.0000000000003117] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2024] [Accepted: 06/05/2024] [Indexed: 07/28/2024] Open
Abstract
BACKGROUND AND OBJECTIVES Studying malpractice claims is important to improve quality of health care and patient safety and to educate the individual healthcare providers. The objective of this study was to describe characteristics of neurosurgical claims in the Netherlands. METHODS A nationwide retrospective observational study of neurosurgery-related claims closed by Centramed and MediRisk, 2 major insurance companies in the Netherlands, was performed. Relevant data, including type of neurosurgical pathology, theme and category of the claim, type and severity of injury, outcome, and financial burden, were extracted from anonymized claim files. The estimated annual risk was used to determine the risk for claims by adjusting for the number of annually practicing neurosurgeons in the Netherlands. RESULTS A total of 388 claims against neurosurgeons were closed between 2007 and 2021. Liability was denied in a slight majority of claims (n = 230; 59%). The total burden during this period was €6 165 000 (amount paid out to patients: €5 497 000). The estimated annual risk per Dutch neurosurgeon for a claim was 15.5%, meaning 1 claim per 6.5 years. The case-level analysis of 238 available anonymized claims revealed that most claims were related to spinal pathology (81.5%), followed by cranial pathology (10.9%) and peripheral nerve (7.6%). The motivations for filing claims were mostly related to alleged surgical (56.3%) or diagnostic errors (22.3%). Most of these claims were denied (151/238; 63.4%), and fewer were settled (42/238; 17.6%), sustained (31/238; 13.0%), or closed without final decision (14/238; 5.9%). CONCLUSION Neurosurgery-related malpractice claims primarily involved spinal pathology and were mostly related to alleged treatment errors. Most claims did not result in compensation because there seemed to be no liability or culpable injury. However, the annual risk for a claim for Dutch neurosurgeons is considerable.
Collapse
Affiliation(s)
- Wouter J Dronkers
- Department of Neurosurgery, Erasmus University Medical Centre Rotterdam, Rotterdam, The Netherlands
| | - Dennis R Buis
- Department of Neurosurgery, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
- Amsterdam Neuroscience Centre, Neurovascular Disease, Amsterdam, The Netherlands
| | - Quirine J M A Amelink
- Department of Legal Affairs, The Dutch Health and Youth Care Inspectorate, Utrecht, The Netherlands
- Erasmus University Rotterdam, Erasmus School of Health Policy and Management, Rotterdam, The Netherlands
| | - Gert-Joan Bouma
- Department of Neurosurgery, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
- Amsterdam Neuroscience Centre, Neurovascular Disease, Amsterdam, The Netherlands
| | - Wilco C Peul
- Department of Neurosurgery, Leiden University Medical Center, Leiden, The Netherlands
- Department of Neurosurgery, Haaglanden Medical Center, The Hague, The Netherlands
| | - W Peter Vandertop
- Department of Neurosurgery, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
- Amsterdam Neuroscience Centre, Neurovascular Disease, Amsterdam, The Netherlands
| | - Marike L D Broekman
- Department of Neurosurgery, Leiden University Medical Center, Leiden, The Netherlands
- Department of Neurosurgery, Haaglanden Medical Center, The Hague, The Netherlands
| | - Aart C Hendriks
- Faculty of Law, Leiden University School of Law, Leiden, The Netherlands
| | - Clemens M F Dirven
- Department of Neurosurgery, Erasmus University Medical Centre Rotterdam, Rotterdam, The Netherlands
| | - Jochem K H Spoor
- Department of Neurosurgery, Erasmus University Medical Centre Rotterdam, Rotterdam, The Netherlands
| |
Collapse
|
3
|
Impact of System and Diagnostic Errors on Medical Litigation Outcomes: Machine Learning-Based Prediction Models. Healthcare (Basel) 2022; 10:healthcare10050892. [PMID: 35628029 PMCID: PMC9140545 DOI: 10.3390/healthcare10050892] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2022] [Revised: 05/07/2022] [Accepted: 05/10/2022] [Indexed: 12/07/2022] Open
Abstract
No prediction models using use conventional logistic models and machine learning exist for medical litigation outcomes involving medical doctors. Using a logistic model and three machine learning models, such as decision tree, random forest, and light-gradient boosting machine (LightGBM), we evaluated the prediction ability for litigation outcomes among medical litigation in Japan. The prediction model with LightGBM had a good predictive ability, with an area under the curve of 0.894 (95% CI; 0.893–0.895) in all patients’ data. When evaluating the feature importance using the SHApley Additive exPlanation (SHAP) value, the system error was the most significant predictive factor in all clinical settings for medical doctors’ loss in lawsuits. The other predictive factors were diagnostic error in outpatient settings, facility size in inpatients, and procedures or surgery settings. Our prediction model is useful for estimating medical litigation outcomes.
Collapse
|
5
|
Kandregula S, Lefever D, Trosclair K, Savardekar A, Menger R, Agarwal N, Kimmell K, Mazzola C, Cozzens J, Rosenow J, Schirmer C, Guthikonda B. "There's got to be a better way": Global Perspectives of Medicolegal Environment and Neurosurgical Socioeconomics. World Neurosurg 2021; 151:341-347. [PMID: 34243667 DOI: 10.1016/j.wneu.2021.04.074] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2021] [Revised: 04/13/2021] [Accepted: 04/15/2021] [Indexed: 10/20/2022]
Abstract
Neurosurgery is considered to have one of the greatest risks of medical malpractice claims. However, medicolegal issues in neurosurgery are often disregarded and underrated worldwide. Medical errors in the neurosurgical field can be attributed to multiple factors, including highly morbid pathologies, the technical difficulty of neurosurgical procedures, and the involvement and interaction of a multidisciplinary team in the care of neurosurgical patients. Health care providers worldwide are at risk of lawsuits, sometimes even when no deviation from the standard of care had occurred in a given case. Often, governments use additional tactics to decrease the burden on compensators and extrajudicial institutions and to decrease the court's flow of irrational litigation. Continuous amendments to health care acts and newer reforms to address these issues have materialized worldwide. In the present narrative review, we have reviewed the global perspectives of medicolegal issues, with a focus on neurosurgical discipline.
Collapse
Affiliation(s)
- Sandeep Kandregula
- Department of Neurosurgery, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA
| | - Devon Lefever
- Department of Neurosurgery, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA
| | - Krystle Trosclair
- Department of Neurosurgery, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA
| | - Amey Savardekar
- Department of Neurosurgery, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA
| | - Richard Menger
- Department of Neurosurgery, Department of Political Science, University of South Alabama, Mobile, Alabama, USA
| | - Nitin Agarwal
- Department of Neurosurgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
| | - Kristopher Kimmell
- Department of Neurosurgery, University of Rochester Medical Center, Rochester, New York, USA
| | - Catherine Mazzola
- Department of Neurosurgery, NJ Craniofacial Center, Newark, New Jersey, USA
| | - Jeffrey Cozzens
- Department of Neurosurgery, Southern Illinois University, Springfield, Illinois, USA
| | - Joshua Rosenow
- Department of Neurosurgery, Northwestern School of Medicine, Chicago, Illinois, USA
| | - Clemens Schirmer
- Department of Neurosurgery, Geisinger Neuroscience Institute, Geisinger Health System, Wilkes-Barre, Pennsylvania, USA
| | - Bharat Guthikonda
- Department of Neurosurgery, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA.
| | | |
Collapse
|